749 related articles for article (PubMed ID: 27110648)
1. Exploitation of lipid-polymeric matrices at nanoscale for drug delivery applications.
Sgorla D; Bunhak ÉJ; Cavalcanti OA; Fonte P; Sarmento B
Expert Opin Drug Deliv; 2016 Sep; 13(9):1301-9. PubMed ID: 27110648
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.
Cheow WS; Hadinoto K
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):214-20. PubMed ID: 21439797
[TBL] [Abstract][Full Text] [Related]
3. Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks.
Zhang RX; Ahmed T; Li LY; Li J; Abbasi AZ; Wu XY
Nanoscale; 2017 Jan; 9(4):1334-1355. PubMed ID: 27973629
[TBL] [Abstract][Full Text] [Related]
4. Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery.
Rao S; Prestidge CA
Expert Opin Drug Deliv; 2016; 13(5):691-707. PubMed ID: 26866382
[TBL] [Abstract][Full Text] [Related]
5. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
[TBL] [Abstract][Full Text] [Related]
6. Preparation of lipid nanoparticles with high loading capacity and exceptional gastrointestinal stability for potential oral delivery applications.
Wang T; Xue J; Hu Q; Zhou M; Luo Y
J Colloid Interface Sci; 2017 Dec; 507():119-130. PubMed ID: 28780331
[TBL] [Abstract][Full Text] [Related]
7. Solid lipid nanocarriers in drug delivery: characterization and design.
Mu H; Holm R
Expert Opin Drug Deliv; 2018 Aug; 15(8):771-785. PubMed ID: 30064267
[TBL] [Abstract][Full Text] [Related]
8. Polymeric Lipid Hybrid Nanoparticles: Properties and Therapeutic Applications.
Jose C; Amra K; Bhavsar C; Momin M; Omri A
Crit Rev Ther Drug Carrier Syst; 2018; 35(6):555-588. PubMed ID: 30317969
[TBL] [Abstract][Full Text] [Related]
9. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
Abdel-Mottaleb MM; Neumann D; Lamprecht A
Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002
[TBL] [Abstract][Full Text] [Related]
10. Lipid-coated polymeric nanoparticles for cancer drug delivery.
Krishnamurthy S; Vaiyapuri R; Zhang L; Chan JM
Biomater Sci; 2015 Jul; 3(7):923-36. PubMed ID: 26221931
[TBL] [Abstract][Full Text] [Related]
11. Solid lipid microparticles as an approach to drug delivery.
Scalia S; Young PM; Traini D
Expert Opin Drug Deliv; 2015 Apr; 12(4):583-99. PubMed ID: 25391992
[TBL] [Abstract][Full Text] [Related]
12. Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery.
Dilnawaz F
Curr Med Chem; 2017; 24(22):2423-2438. PubMed ID: 27804879
[TBL] [Abstract][Full Text] [Related]
13. Synthetic surfactant- and cross-linker-free preparation of highly stable lipid-polymer hybrid nanoparticles as potential oral delivery vehicles.
Wang T; Xue J; Hu Q; Zhou M; Chang C; Luo Y
Sci Rep; 2017 Jun; 7(1):2750. PubMed ID: 28584240
[TBL] [Abstract][Full Text] [Related]
14. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
15. Investigations on pharmacokinetics and biodistribution of polymeric and solid lipid nanoparticulate systems of atypical antipsychotic drug: effect of material used and surface modification.
Joseph E; Saha RN
Drug Dev Ind Pharm; 2017 Apr; 43(4):678-686. PubMed ID: 28044468
[TBL] [Abstract][Full Text] [Related]
16. Solid lipid nanoparticles as drug delivery systems.
Manjunath K; Reddy JS; Venkateswarlu V
Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):127-44. PubMed ID: 15834465
[TBL] [Abstract][Full Text] [Related]
17. Bioactivity of Hybrid Polymeric Magnetic Nanoparticles and Their Applications in Drug Delivery.
Mohammed L; Ragab D; Gomaa H
Curr Pharm Des; 2016; 22(22):3332-52. PubMed ID: 26853596
[TBL] [Abstract][Full Text] [Related]
18. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part II - Ocular drug-loaded lipid nanoparticles.
Sánchez-López E; Espina M; Doktorovova S; Souto EB; García ML
Eur J Pharm Biopharm; 2017 Jan; 110():58-69. PubMed ID: 27789359
[TBL] [Abstract][Full Text] [Related]
19. Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery.
Zoubari G; Staufenbiel S; Volz P; Alexiev U; Bodmeier R
Eur J Pharm Biopharm; 2017 Jan; 110():39-46. PubMed ID: 27810471
[TBL] [Abstract][Full Text] [Related]
20. An update on polymer-lipid hybrid systems for improving oral drug delivery.
Maghrebi S; Prestidge CA; Joyce P
Expert Opin Drug Deliv; 2019 May; 16(5):507-524. PubMed ID: 30957577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
